About Us
Products
Image Gallery
News
Publications
Consulting
Licensing
GAWH
Helpful Links
Contact Us
Home Page

1. Markovic O, Markovic N, and BioSciCon Cervical Cancer Study Group. Cervical acid phosphatase: A biomarker of cervical dysplasia and potential surrogate endpoint for colposcopy. Disease Markers 2003/2004;19(6): 279-286.
Click here to view the article.

2. Markovic O. Markovic N. MarkPap® Research Kit
http://www.biocicon.com/markapapproducts.html

3. Markovic N, Markovic O. Enhancing Pap test with a new biological marker of cervical dysplasia International Symposium on Predictive Oncology & Intervention Strategies, Nice, France, 2004. Cancer Detect Prevention 2004 Symposium Volume, S-53(21).
http://www.cancerprev.org/Meetings/2004/Symposia/893

4. Markovic O, Markovic N, and BioSciCon Cervical Cancer Study Group. MarkPap™ Kit. Cancer Detect Prevention, 2004 Symposium Volume, S-149(318).
http://www.cancerprev.org/Meetings/2004/Symposia/992

5. Markovic O, Markovic N, et al. Cervical acid phosphatase: A new biomarker of cervical dysplasia. Arch Oncol 2003;11:243-247.
Http://scindeks.nb.rs/article.aspx?artid=0354-73100304243M

6. Markovic O, Markovic N, Sundeen J, Smith W. Jr. A cytoplasmic biomarker for liquid-based Pap. The FACEB J. Experimental Biology 2004, Abstracts Part 1, A200 (151.12).

7. Smith W Jr, Markovic N, Markovic O, Kumar A, Bermeyo S, Mollish P, late Morris M. MarkPap™ System for cervical cancer screening. Power Point presentation at the 2004 Biannial Meeting of the American Society for Colposcopy and Cervical Pathology. Disney's Contemporary Resort, FL. 2004 ASCCP Book of Abstracts, p.340.

8. Townsend L, Markovic O, Markovic N, BioSciCon Cervical Cancer Study Group. MarkPap™test reduces false-negative rates of cervical cancer screening Obst Gynec 2004 Suppl; 103(4):81S.

9. Markovic NS, Markovic O, Sundeen J, Smith W, Jr., Markovic SN, BioSciCon Cervical Cancer Study Group. Pap test and new biomarker-based technology for enhancing visibility of abnormal cells. ASCO 2004, New Orleans, Louisiana. J Clin Oncol 2004; 22:9561.
Click here for the article

10. Markovic N, Markovic O, Sundeen J, Smith W. Jr. Cervical Acid Phosphatase and PreservCyt®. Inv Medicine 2004; 52 Suppl 2: 80.

11. Markovic N, Markovic O. MarkPap® technology. From idea to commercial products. A biomarker based, in vitro diagnostic device with potentials for cervical cancer screening. 2004, 3rd Annual Early Detection Research Network Meeting, EDRN NIH, Bethesda, MD.

12. Markovic O, Markovic N, BioSciCon Cervical Cancer Study Group. MarkPap® Technology for cervical cancer screening. 2004, 6th Annual SBIR/STTR Conference, NIH, Bethesda, MD.

13. Markovic O, Markovic N, Kemp C. Could the enzyme-enhanced Pap test be automated? The FACEB J, Experimental Biology 2004, Abstracts Part 1, A200 (151.10).

14. BioSciCon Business Presentation, 2003
Click here to view the presentation

15. Markovic O, Markovic N, Cervical Cancer Study Group. MarkPap® System for cervical cancer screening and for molecule-targeting cancer therapy. EB 2005, FASEB J, 2005, 18. Online Abstract Itinerary

16. Markovic N, Markovic O, Henderson E, BioSciCon Cervical Study Group. MarkPap® test for cervical cancer screening. 2005 Annual Meeting of the American Society for Clinical Oncology (ASCO, 2005).
Click here to view the presentation
J Clin Oncol 2005;23,16S:1021.
Click here to view the abstract

17. BioSciCon Business Presentation, 2006
Click here to view the presentation

18. Markovic N, Markovic O, Parr S, Zizic V. MarkPap(r) technology for cervical cancer control. BIO 2005 Convention. You will find a link to the abstract on this page:
http://www.bio.org/events/2005/poster/posteronline/index.asp

19. Markovic O, Markovic N. Biomarker improves the accuracy of Papanicolaou-based screening for cervical dysplasia. Abstracts of Papers and Poster Presentations, 2005 Scientific Sessions of the Annual Meeting of the Society for Clinical Pathology (ASCP), Seattle, WA (Abstract # 19). http://www.ajcp.com/Oct05Abstracts.pdf.

20. Markovic N, Markovic O. MarkPap Test and papillomavirus–infected cells. Abstracts of Papers and Poster Presentations, Scientific Sessions of the Annual Meeting of the Society for Clinical Pathology (ASCP), October 2005, Seattle, WA (Abstract # 35). http://www.ajcp.com/Oct05Abstracts.pdf.

21. Markovic O, Markovic N. MarkPap® System. Current status and prospective. 2005 Annual Meeting of the American Society for Cytopathology, San Diego, CA (Abstract # 39).

22. Markovic O, Markovic N, Hankins D, McJonathan S, Hill G. New prospective for MarkPap® technology for cervical cancer control. BIO 2006 Convention, Innovative Corridor, April 2006, Chicago, IL.
Click here to view this presentation.

23. Markovic N, Markovic O, Henderson E. MarkPap Digital, a new prospective for biomarker-based gynecological cytology. Annual Meeting of the American Association for Cancer Research (AACR), April 2006, Washington, DC.
Click here to view the abstract.

24. Markovic N, Markovic O. MarkPap® test, a potential method for monitoring the success of HPV vaccination. Clinical Research 2006, Annual Meeting of the American Federation for Clinical Research (AFCR), March 2006, Washington, DC. J Investigative Medicine 54, (2), S381, 2006.
Click here to view the abstract.

25. Markovic O, Markovic N, Townsend L, Smith W Jr, Hankins D, Cotic M, McJonathan S. Pap test moves into doctor's offices. Clinical Research 2006, Annual Meeting of the American Federation for Clinical Research (AFCR), March 2006, Washington, DC. J Investigative Medicine 54, (2), S381, 2006.
Click here to view the abstract.

26. Markovic N, Markovic O, BioSciCon Cervical Cancer Study Group: Biomarker-based telecytopathology: A new prospective for global cervical cancer control. 4th Early Detection Research Network, National Cancer Institute, NIH, Philadelphia, March 2006, Philadelphia, PA 2006. Book of Abstracts, 23, 2006.
Click here to view the abstract.

27. Markovic O., Markovic N. MarkPap technology, new deployment. FASEB Annual Meeting, Experimental Biology 2006, San Francisco, CA : Abstract LB 540.
Click here to view the abstract.

28. Markovic O, Markovic N. MarkPap technology: A prospective for global cervical cancer control. FASEB Annual Meeting, Experimental Biology 2006, San Francisco, CA.
Click here to view the abstract.

29. Markovic N, Markovic O. MarkPap(r) technology, a new business opportunity for the Mid-Atlantic biotechnology . Mid-Atlantic BIO 2006, Washington DC. To see the abstract of the presentation click here.

30. Markovic N, Markovic O. Cytopathology between art and science. Experimental Biology 2007. The FASEB J 2007: 21 (6), A 775.
http://www.fasebj.org/cgi/content/meeting_abstract/21/6/A775-c

31. Markovic O, Markovic N. Will Home Pap Test be soon available? Experimental Biology 2007. The FASEB J 2007 : 21 (6), A 754, 708.10
Click here to view the article.

32. Markovic N, Markovic O. MarkPap test and HPV vaccination. BIO International Convention, BIO 2007, Innovation Corridor. Boston, MA, 2007.
http://72.14.209.104/Poster/Listing.aspx

33. Markovic N. Chediack-Higashi-Like granules in acute promyelocytoc leukemia.Blood, 92(9), 3475-3477, 1989
http://bloodjournal.hematologylibrary.org/cgi/content/full/92/9/3475

34. Markovic N. BioSciCon presents the MarkPap technology. Larta-CAP Venture Forum 2007, San Francisco, CA, May 2007.
http://www.theventureforum.com/PresentingCompaniesList.asp

35. BioSciCon Past, Present and Future. Business presentation, 2007.
Click here to download the PowerPoint Presentation.

36. Markovic N, Markovic O. Biomarker Plus. 55th Annual Meeting of the American Society of Cytopathology, Nov 2007, Houston, Texas. Cancer Cytopathology Suppl. 11/5,385,2007
Click here to download the abstract. (PDF format)

37. Markovic N, Markovic O. Ask for women' s opinion first. Teaching and Computer Session. FASEB Experimental Biology, 2008. Today's Research: Tomorrow's Health. San Diego California, April 5-9, 2008.
Click here to download the abstract.

38. Deb Prabal, Iyer Wenkateswaran, Bhatla Neerja, Olivera Markovic, Verma Kusum. Cervical acid phosphatase detection: A guide to abnormal cells in cytology smear screening for cervical cancer. Journal of Cytology, 25 (1),1-5, 2008.
Click here to view the article.

39. Markovic N, Markovic O, Panashchenko O, McJonathan S. A tool for integration of cytology, HPV screening and telecytopathology. BIO 2008 International Convention. San Diego, California, June 2008.
Click here to download the abstract.

40. Markovic N, Markovic O. What Every Women Should Know about Cervical Cancer (Springer, 2008).
Now available at Amazon.com.

41. Markovic O, Markovic N. IT enables same-day Pap test. Experimental Biology 2009, FASEB, April 2009.
Click here to view the abstract.

42. Markovic O, Markovic N. Cell phones as a new m-Health opportunity for mass cervical cancer screening. Experimental Biology 2010, FASEB, April 2010. Click here to view the abstract.

43. MarkPap® Technology, A guide to navigate through the web Site www.bioscicon.com.
Covering the Consortium companies, the technology, business and other related issues, web site www.bioscicon.com is rather comprehensive. This PowerPoint presentation will help you to navigate through the Web Site and get information on the subjects you are particularly interested in. Click here to view the presentation.

44. BioSciCon's most recent Advances in Wireless Telecytopathology. Click here to view the document.

45. Markovic N, Markovic O. Capitalization of investing into medical device development on the health market. 2011 National Annual SBIR/STTR conference, NIH, Bethesda, MD, June 2011. Book pf abstracts, 2011.
grants.nih.gov/grants/funding/SBIRConf2011/docs/Abstracts_for_printing.pdf grants.nih.gov/grants/funding/SBIRConf2011/poster.html
Click here to download the abstract.

46. Markovic O, Markovic N. Further studies on the application of wireless cytopathology for detection of cervical cancer and initial screening for oral cancer. FASEB National Meeting, Experimental Biology 2011, Washington, DC, April 2011.
Click here to download the abstract.

47. Markovic N, Markovic O. Low cost medical devices combined with telemedicine reduce health disparities between developed and underdeveloped countries. National NIH Conference on Cancer Detection and Diagnostics Technologies for Global Health. Bethesda, MD, August 2011. Book of Abstracts, p. 138.
Click here to download the abstract.

48. Markovic O, Markovic N. Is mass cytological cancer screening possible worldwide? The FASEB Journal 26, 657.1, 2012
Click here to view the abstract.

49. Markovic O, Markovic N. Universal Adapter for Telecytopathology. The FASEB Journal 26, 1b476, 2012
Click here to view the abstract.

50. Markovic O, Markovic N. IT Telehealth Center for Telecytopathology. The FASEB Journal 27:874.20, 2013
Click here to view the abstract.

51. Iyer VK, Mathur SR, Bhatla N, Markovic O. Evaluation of Cytology Screening Strategies for Cervical Cancer In Resource Poor Setting. 18th International Congress of Cytology, Paris May 2013.
Click here to view the abstract.

52. Markovic O, Markovic N. Meeting the recommendations for cervical cancer screening in developing counties. 2014 National Conference on Cancer Detection, Diagnosis and Treatment for Global Health. NIH, Bethesda, MD, January 2014.
Click here to view.

53. Markovic N, Markovic O. Changing bioactivity of live cancer cells in vitro.. 2014 National Conference on Cancer Detection, Diagnosis and Treatment for Global Health. NIH, Bethesda, MD, January 2014.
Click here to view.

54. Markovic O, Markovic N. Missing link.. NIH Second Single Cell Analysis Investigators Conference, Bethesda, MD, 2014.
Click here to view the abstract.

55. Flyer for display at the NIH Second Single Cell Analysis Investigators Conference, Bethesda, MD, 2014.
Click here to view.

56. A New Composite Biomarker for Cervical Cancer Diagnosis. The FASEB Journal 30, 1, Supplement 696.5, 2016.
Click here to view abstract.

57. Markovic O. Could we treat patients with cancer, not cancer with patients. Cancer Oncology, 2016 Virtual Event. October 5-6, 2016. www.labroots.com/virtual-event.
Read more....
Link to eAbstract video "Could we treat patients with cancer, not cancer with patients?".

58. Markovic N. POC's past, present and future. IT empowering POC's. A need to equal health care for all. Labroots Clinical Diagnostic and Research Virtual Meeting, Nov 2-3, 2016. www.labroots.com/virtual-event.
Click here to view Virtual Event Poster.
Read more....

59. Markovic N, Markovic O. What every woman should know about cervical cancer. Second, updated and extended edition. Springer, Netherlands, 2017. What Every Woman Should Know about Cervical Cancer, 2nd Edition

60. Markovic O, Markovic N. Cervical Cancer and HPV: Dilemmas and Resolutions via Biomarkers. FASEB J. Vol 131, Suppl. 807.9.2017.
Click here to view the Abstract.